Development and validation of nomograms predictive of axillary nodal status to guide surgical decision-making in early-stage breast cancer

Jiao Li, Weimei Ma, Xinhua Jiang, Chunyan Cui, Hongli Wang, Jiewen Chen, Runcong Nie, Yaopan Wu, Li Li

Research output: Contribution to journalArticle

Abstract

Purpose: To develop and validate nomogram models using noninvasive imaging parameters with related clinical variables to predict the extent of axillary nodal involvement and stratify treatment options based on the essential cut-offs for axillary surgery according to the ACOSOG Z0011 criteria. Materials and Methods: From May 2007 to December 2017, 1799 patients who underwent preoperative breast and axillary magnetic resonance imaging (MRI) were retrospectively studied. Patients with data on axillary ultrasonography (AUS) were enrolled. The MRI images were interpreted according to Breast Imaging Reporting and Data system (BI-RADS). Using logistic regression analyses, nomograms were developed to visualize the associations between the predictors and each lymph node (LN) status endpoint. Predictive performance was assessed based on the area under the receiver operating characteristic curve (AUC). Bootstrap resampling was performed for internal validation. Goodness-of-fit of the models was evaluated using the Hosmer-Lemeshow test. Results: Of 397 early breast cancer patients, 200 (50.4%) had disease-free axilla, 119 (30.0%) had 1 or 2 positive LNs, and 78 (19.6%) had ≥3 positive LNs. Patient age, MRI features (mass margin, LN margin, presence/absence of LN hilum, and LN symmetry/asymmetry), and AUS descriptors (presence of cortical thickening or hilum) were identified as predictors of nodal disease. Nomograms with these predictors showed good calibration and discrimination; the AUC was 0.809 for negative axillary node (N0) vs. any LN metastasis, 0.749 for 1 or 2 involved nodes vs. N0, and 0.874 for ≥3 nodes vs. ≤2 metastatic nodes. The predictive ability of the 3 nomograms with additional pathological variables was significantly greater. Conclusion: The nomograms could predict the extent of ALN metastasis and facilitate decision-making preoperatively.

Original languageEnglish (US)
Pages (from-to)1263-1274
Number of pages12
JournalJournal of Cancer
Volume10
Issue number5
DOIs
StatePublished - Jan 1 2019

Fingerprint

Nomograms
Decision Making
Lymph Nodes
Breast Neoplasms
Magnetic Resonance Imaging
Area Under Curve
Ultrasonography
Breast
Neoplasm Metastasis
Axilla
Aptitude
Information Systems
ROC Curve
Calibration
Logistic Models
Regression Analysis

Keywords

  • Breast cancer
  • Lymph node
  • Magnetic resonance imaging
  • Metastasis
  • Ultrasonography

ASJC Scopus subject areas

  • Oncology

Cite this

Development and validation of nomograms predictive of axillary nodal status to guide surgical decision-making in early-stage breast cancer. / Li, Jiao; Ma, Weimei; Jiang, Xinhua; Cui, Chunyan; Wang, Hongli; Chen, Jiewen; Nie, Runcong; Wu, Yaopan; Li, Li.

In: Journal of Cancer, Vol. 10, No. 5, 01.01.2019, p. 1263-1274.

Research output: Contribution to journalArticle

Li, Jiao ; Ma, Weimei ; Jiang, Xinhua ; Cui, Chunyan ; Wang, Hongli ; Chen, Jiewen ; Nie, Runcong ; Wu, Yaopan ; Li, Li. / Development and validation of nomograms predictive of axillary nodal status to guide surgical decision-making in early-stage breast cancer. In: Journal of Cancer. 2019 ; Vol. 10, No. 5. pp. 1263-1274.
@article{87e2b515b7794e87a4fdfa70321358e6,
title = "Development and validation of nomograms predictive of axillary nodal status to guide surgical decision-making in early-stage breast cancer",
abstract = "Purpose: To develop and validate nomogram models using noninvasive imaging parameters with related clinical variables to predict the extent of axillary nodal involvement and stratify treatment options based on the essential cut-offs for axillary surgery according to the ACOSOG Z0011 criteria. Materials and Methods: From May 2007 to December 2017, 1799 patients who underwent preoperative breast and axillary magnetic resonance imaging (MRI) were retrospectively studied. Patients with data on axillary ultrasonography (AUS) were enrolled. The MRI images were interpreted according to Breast Imaging Reporting and Data system (BI-RADS). Using logistic regression analyses, nomograms were developed to visualize the associations between the predictors and each lymph node (LN) status endpoint. Predictive performance was assessed based on the area under the receiver operating characteristic curve (AUC). Bootstrap resampling was performed for internal validation. Goodness-of-fit of the models was evaluated using the Hosmer-Lemeshow test. Results: Of 397 early breast cancer patients, 200 (50.4{\%}) had disease-free axilla, 119 (30.0{\%}) had 1 or 2 positive LNs, and 78 (19.6{\%}) had ≥3 positive LNs. Patient age, MRI features (mass margin, LN margin, presence/absence of LN hilum, and LN symmetry/asymmetry), and AUS descriptors (presence of cortical thickening or hilum) were identified as predictors of nodal disease. Nomograms with these predictors showed good calibration and discrimination; the AUC was 0.809 for negative axillary node (N0) vs. any LN metastasis, 0.749 for 1 or 2 involved nodes vs. N0, and 0.874 for ≥3 nodes vs. ≤2 metastatic nodes. The predictive ability of the 3 nomograms with additional pathological variables was significantly greater. Conclusion: The nomograms could predict the extent of ALN metastasis and facilitate decision-making preoperatively.",
keywords = "Breast cancer, Lymph node, Magnetic resonance imaging, Metastasis, Ultrasonography",
author = "Jiao Li and Weimei Ma and Xinhua Jiang and Chunyan Cui and Hongli Wang and Jiewen Chen and Runcong Nie and Yaopan Wu and Li Li",
year = "2019",
month = "1",
day = "1",
doi = "10.7150/jca.32386",
language = "English (US)",
volume = "10",
pages = "1263--1274",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "5",

}

TY - JOUR

T1 - Development and validation of nomograms predictive of axillary nodal status to guide surgical decision-making in early-stage breast cancer

AU - Li, Jiao

AU - Ma, Weimei

AU - Jiang, Xinhua

AU - Cui, Chunyan

AU - Wang, Hongli

AU - Chen, Jiewen

AU - Nie, Runcong

AU - Wu, Yaopan

AU - Li, Li

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: To develop and validate nomogram models using noninvasive imaging parameters with related clinical variables to predict the extent of axillary nodal involvement and stratify treatment options based on the essential cut-offs for axillary surgery according to the ACOSOG Z0011 criteria. Materials and Methods: From May 2007 to December 2017, 1799 patients who underwent preoperative breast and axillary magnetic resonance imaging (MRI) were retrospectively studied. Patients with data on axillary ultrasonography (AUS) were enrolled. The MRI images were interpreted according to Breast Imaging Reporting and Data system (BI-RADS). Using logistic regression analyses, nomograms were developed to visualize the associations between the predictors and each lymph node (LN) status endpoint. Predictive performance was assessed based on the area under the receiver operating characteristic curve (AUC). Bootstrap resampling was performed for internal validation. Goodness-of-fit of the models was evaluated using the Hosmer-Lemeshow test. Results: Of 397 early breast cancer patients, 200 (50.4%) had disease-free axilla, 119 (30.0%) had 1 or 2 positive LNs, and 78 (19.6%) had ≥3 positive LNs. Patient age, MRI features (mass margin, LN margin, presence/absence of LN hilum, and LN symmetry/asymmetry), and AUS descriptors (presence of cortical thickening or hilum) were identified as predictors of nodal disease. Nomograms with these predictors showed good calibration and discrimination; the AUC was 0.809 for negative axillary node (N0) vs. any LN metastasis, 0.749 for 1 or 2 involved nodes vs. N0, and 0.874 for ≥3 nodes vs. ≤2 metastatic nodes. The predictive ability of the 3 nomograms with additional pathological variables was significantly greater. Conclusion: The nomograms could predict the extent of ALN metastasis and facilitate decision-making preoperatively.

AB - Purpose: To develop and validate nomogram models using noninvasive imaging parameters with related clinical variables to predict the extent of axillary nodal involvement and stratify treatment options based on the essential cut-offs for axillary surgery according to the ACOSOG Z0011 criteria. Materials and Methods: From May 2007 to December 2017, 1799 patients who underwent preoperative breast and axillary magnetic resonance imaging (MRI) were retrospectively studied. Patients with data on axillary ultrasonography (AUS) were enrolled. The MRI images were interpreted according to Breast Imaging Reporting and Data system (BI-RADS). Using logistic regression analyses, nomograms were developed to visualize the associations between the predictors and each lymph node (LN) status endpoint. Predictive performance was assessed based on the area under the receiver operating characteristic curve (AUC). Bootstrap resampling was performed for internal validation. Goodness-of-fit of the models was evaluated using the Hosmer-Lemeshow test. Results: Of 397 early breast cancer patients, 200 (50.4%) had disease-free axilla, 119 (30.0%) had 1 or 2 positive LNs, and 78 (19.6%) had ≥3 positive LNs. Patient age, MRI features (mass margin, LN margin, presence/absence of LN hilum, and LN symmetry/asymmetry), and AUS descriptors (presence of cortical thickening or hilum) were identified as predictors of nodal disease. Nomograms with these predictors showed good calibration and discrimination; the AUC was 0.809 for negative axillary node (N0) vs. any LN metastasis, 0.749 for 1 or 2 involved nodes vs. N0, and 0.874 for ≥3 nodes vs. ≤2 metastatic nodes. The predictive ability of the 3 nomograms with additional pathological variables was significantly greater. Conclusion: The nomograms could predict the extent of ALN metastasis and facilitate decision-making preoperatively.

KW - Breast cancer

KW - Lymph node

KW - Magnetic resonance imaging

KW - Metastasis

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=85061637368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061637368&partnerID=8YFLogxK

U2 - 10.7150/jca.32386

DO - 10.7150/jca.32386

M3 - Article

AN - SCOPUS:85061637368

VL - 10

SP - 1263

EP - 1274

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 5

ER -